viewIncanthera Ltd

Incanthera submits new patent application for cancer preventing sun cream

If granted, it will further extend the life of the patent family protecting Sol to 2041

Incanthera Ltd -

Incanthera PLC (AQSE:INC) said it has filed a new patent application covering its Sol sun cream used to prevent a skin condition called solar keratosis and related cancers.

If granted, it will further extend the life of the patent family protecting Sol to 2041.

“This new patent filing demonstrates the robust foundations of our Sol programme and strengthens the commercial protection for the product,” Incanthera chairman Tim McCarthy said in a statement. “We are looking forward to the next steps as we bring Sol forward to market-facing partners.”

Sol has already completed the proof of concept stage and Incanthera is looking for a partner to help it through the product development and marketing stage.

Originally spun-out from Bradford University’s Institute of Cancer Therapeutics, the technology uses a formulation and prodrug targeting technologies to deliver treatment specifically to the tumour.

Quick facts: Incanthera Ltd

Price: 16 GBX

Market: AQSE
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Incanthera Ltd named herein, including the promotion by the Company of Incanthera Ltd in any Content on the Site, the Company receives from...



Incanthera says it's making great progress towards commercialisation of lead...

Incanthera's (LON:INC) Simon Ward and Tim McCarthy speak to Proactive following the release of its first set of results since listing earlier this year on the AQSE Growth Market. CEO ward describes it as a pivotal year for the company and says they're now fully focused on further development...

on 15/6/20

2 min read